etoposide has been researched along with Cataract in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nallasamy, S; Ramasubramanian, A; Shields, CL; Shields, JA; Tipperman, R | 1 |
Berglund, A; Carlson, K; Enblad, G; Glimelius, B; Hagberg, H | 1 |
2 other study(ies) available for etoposide and Cataract
Article | Year |
---|---|
Chemoreduction for nonvisualized retinoblastoma hidden behind dense cataract.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cataract; Cataract Extraction; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Magnetic Resonance Imaging; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 2010 |
Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cataract; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infections; Life Tables; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prognosis; Remission Induction; Retrospective Studies; Survival Analysis; Sweden; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2000 |